Main Body
NYMAC
NYMAC
(New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services)
NYMAC Region
Pharmacogenetics: Individual Genetic Responses to Drugs and Medications - April 7, 2006
Topics & Speakers
- Pharmacogenetics Overview
- Bonny L. Bukaveckas, PhD
Assistant Professor of Pharmacy & Pathology
Virginia Commonwealth University
- Bonny L. Bukaveckas, PhD
- Pharmacogenetics of Toxicity of Anti-Cancer Drugs
- Matthew D. Krasowski, MD, PhD
Assistant Professor, Division of Clinical Chemistry
University of Pittsburgh
- Matthew D. Krasowski, MD, PhD
- Asthma Treatment
- John J. Lima, PharmD
Director, Center for Clinical Pediatric Pharmacology
Co-Director, Pharmacogenetics Center
Nemours Children's Clinic
- John J. Lima, PharmD
- Aminoglycoside Ototoxicity
- Walter E. Nance, MD, PhD
Professor of Human Genetics, Medicine & Pediatrics
Medical College of Virginia
- Walter E. Nance, MD, PhD
- Cytochrome P450
- Laurence S. Kaminsky, PhD
Chief, Laboratory of Human Toxicology & Molecular Epidemiology
Deputy Division Director, Division of Environmental Disease Prevention
New York State Department of Health
- Laurence S. Kaminsky, PhD
- HER-2 in Breast Cancer
- Mark E. Robson, MD
Clinic Director, Clinical Genetics Services
Memorial Sloan-Kettering Cancer Center
- Mark E. Robson, MD




